Shaping African
Precision Oncology For a Better Tomorrow
We're building the next generation of liquid biopsy multi-cancer early-detection tests using uniquely African datasets for enhanced precision and reduced clinical bias.
We're building that here, in Africa.
From Africa, to the World.
WHY LIQUID BIOPSY?
Liquid biopsy screens provide several advantages over traditional tissue biopsies, most notably it's comparatively low invasiveness.
For patients for which tissue-based testing is not appropriate or available, liquid biopsy can provide a safe alternative for diagnosis.
HOW IT WORKS
01
BLOOD DRAW
A blood sample is all we need to confirm or make a primary diagnosis. No invasive surgeries, no delays.
02
ANALYSIS
We analyse a proprietary list of the most relevant biomarkers through our state of the art machine learning platform.
03
DIAGNOSIS
We provide a report to the primary care physician outlining the primary diagnosis confirmation and cancer type.
Meet the Team
We're on a mission to change the way cancer is diagnosed. Pleased to meet you.
Everyone needs a little advice sometimes...
The first step to knowing everything is knowing that you don't.
Our advisors cover the four pillars of our core business:
Cancer Biology, Bioinformatics, Ethics, and of course Business.